 Thrombin inhibitory new dihydroxybenzene ether derivatives |
| We claim: 1. An ether derivative of a dihydroxybenzene of the formula ##STR40## wherein the ether ... |
|
| Deer repellent device and method |
| What is claimed is: 1. A deer repellent assembly comprising: a 100 foot length of one-quarter inch ... |
|
| Solid consumer product compositions containing small particle clyclodextrin complexes |
| What is claimed is: 1. Pharmaceutical composition comprising an effective amount of active/... |
|
| Water-dispersible protein/polyurethane reaction product |
| OF THE INVENTION In the process of our invention the isocyanate-capped liquid polyurethane ... |
|
| Polyurethane hydrogels having enhanced wetting rates |
| What we claim is: 1. A method of improving the wetting rate of a water swellable, lightly ... |
|
| Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane |
| OF THE PREFERRED EMBODIMENT In describing the preferred embodiment, certain terminology will be ... |
|
| Transparent impact polymers |
| OF THE INVENTION The monomers of the feed mixture of this invention are selected from three ... |
|
| Oil reclaimer |
| I claim: 1. An apparatus for removing impurities from lubricating oil, comprising, a container ... |
|
|
Aqueous concentrates of salts of .alpha.-sulfonated fatty acid alkyl esters
| Details |
Inventors: Pierr, Robert; Ritterbex, Horst; Jost, Frantisek; Rommerskirchen, Hans J.;
Assignee: Henkel Kommanditgesellschaft auf Aktien (Duesseldorf, DE)
Primary Examiner: Warren; Charles F.
Assistant Examiner: Flaherty; Elizabeth A.
Attorney, Agent or Firm: Szoke; Ernest G., Millson, Jr.; Henry E., Grandmaison; Real J.
Aqueous concentrates of alkali metal salts of .alpha.-sulfonated fatty acid alkyl esters (ester sulfonate salts) which are pumpable at temperatures of at least 60.degree. C. are obtained without the addition of viscosity regulators by preparing pastes containing at least about 60% by weight of ester sulfonate salts derived from C.sub.16 and/or C.sub.18 fatty acids. More particularly, the concentrates contain less than 10 mole % of ester sulfonate salts with fatty acids containing fewer than 16 carbon atoms. The concentrates are obtained by neutralizing the crude ester sulfonates with concentrated alkali hydroxide solution with intensive cooling at temperatures of at most 90.degree. C. |
|
DETAILED DESCRIPTION What is claimed is: 1.
An aqueous paste which can be readily pumped at a temperature of about 60.
degree.
C.
or higher consisting essentially of water and an alkali metal salt of an .
alpha.
-sulfonated fatty acid alkyl ester in which the fatty acid moiety therein is a C.
sub.
16 fatty acid or a C.
sub.
18 fatty acid, or a mixture of such salts, wherein said paste has an ester sulfonate salt solids content of at least about 60% by weight, based on the weight of the paste, and said paste has a viscosity not in excess of 10,000 mPas at a temperature of from about 60.
degree.
to about 70.
degree.
C.
2.
A process for preparing the aqueous paste of claim 1 comprising neutralizing a crude bleached or unbleached .
alpha.
-sulfonated fatty acid alkyl ester in which the fatty acid moiety is a C.
sub.
16 fatty acid, a C.
sub.
18 fatty acid, or a mixture of such esters with a concentrated aqueous alkali metal hydroxide solution to form an ester sulfonate salt paste having a solids content of at least about 60% by weight, while intensively cooling the neutralizing mixture at a level not exceeding about 90.
degree.
C.
3.
A process in accordance with claim 2 wherein the paste has a solids content of from about 60 to about 80% by weight.
4.
A process in accordance with claim 2 wherein the crude .
alpha.
-sulfonated fatty acid alkyl ester sulfonate and the concentrated aqueous alkali metal hydroxide solution are introduced into an intensively stirred and cooled ester sulfonate salt paste having a solids content of at least 60% by weight, and wherein the average residence time of this reaction mixture under the temperature conditions of the neutralization reaction is no more than about 20 minutes.
5.
A process in accordance with claim 2 wherein the concentrated aqueous alkali metal hydroxide solution is a sodium hydroxide solution.
6.
A process in accordance with claim 2 wherein the concentration of the aqueous alkali metal hydroxide solution is in the range of from about 15 to about 50% by weight.
7
|
| Related patents |
|
|
Process for the production of organic fuel
The exact nature of the cellulosic starting material used in the process of this invention is not critical. Virtually any organic material containing cellulose or ...
|
|
|
Process for the fermentative production of acetone, butanol and ethanol
We claim: 1. The improved process for the production of butanol, acetone and ethanol, by the fermentation of an asporogenic microorganism capable of producing butanol, ...
|
|
|
Mutant strain of C. acetobutylicum and process for making butanol
We claim: 1. A method of producing butanol which comprises anaerobically culturing a biologically pure culture of Clostridium acetobutylicum ATCC 55025 in a nutrient ...
|
|
|
Azido-silane compositions
What is claimed is: 1. A solubilized azido-containing silane composition of matter produced by a process which comprises reacting in the presence of a non-aqueous ...
|
|
|
Substituted triazino-benzimidazoles
What we claim is: 1. A triazinobenzimidazole of the formula ##STR36## wherein R.sub.1 is straight-chain or branched alkyl having 1 to 18 carbon atoms; straight-chain or ...
|
|
|
Class of bifunctional additives for bioremediation of hydrocarbon contaminated soils and water
What is claimed is: 1. A method for enhancing microbial degradation of hydrocarbon containing water or soil comprising: contacting the hydrocarbon containing soil or ...
|
|
|
Process for the preparation of halogenomethylketones, in particular of 1,1,1-trifluoroacetone
What is claimes is: 1. Process for the preparation of halogenomethylketones of the formula (I) ##STR4## in which X represents halogen, n represents 1, 2 or 3 and R ...
|
|
|
Antibody-drug conjugates
OF THE INVENTION The present invention pertains to novel immunoconjugates, intermediates thereto, pharmaceutical compositions and methods of use. Throughout the present ...
|
|
|
Monoclonal antibodies against metal chelates
We claim: 1. A monoclonal antibody which exhibits specificity for a complex comprising a chelating agent and a first metallic ion, the antibody having an association ...
|
|
|
Preparation of cyclic carbonates using alkylammonium and tertiary amine catalysts
OF THE INVENTION According to the process of the invention, cyclic carbonates having five or six-membered rings are prepared from the reaction of 1,2- or 1,3-diols and ...
|
|
|
Molecular Biology 
